Surrogacy Market Size & Growth Forecast 2027–2036, By Segments (Technology, Service Provider, Type, Age Group), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to Content
Market Size and Growth Outlook
Surrogacy Market size was valued at USD 32.75 billion in 2026 and is anticipated to grow at a 25.09% CAGR from 2027 to 2036, attaining USD 307.21 billion by 2036. The industry revenue for 2027 is assessed at USD 40 billion.
Get more details on this report
Request Free Sample ReportSurrogacy Market Intelligence Snapshot
Regional Market Dynamics
- North America leads through established fertility clinics, advanced assisted reproductive technologies, specialized healthcare professionals, and structured legal and professional support services that facilitate surrogacy arrangements.
- Asia Pacific is gaining momentum through rising infertility concerns, improving reproductive healthcare infrastructure, and greater awareness of assisted reproductive technologies, although regulatory differences influence service availability across countries.
Segment Momentum
- IVF accounted for 60.86% of the market in 2026 and is also the fastest-growing technology, enabling embryo creation and transfer to gestational carriers while supporting coordinated fertility treatment.
- Fertility clinics held 60.77% of the market in 2026 and are also the fastest-growing service provider segment, offering integrated reproductive assessment, IVF, embryo development, cryopreservation, and transfer procedures.
Market Expansion Drivers
- Increasing infertility rates and delayed parenthood trends.
- Cross-border surrogacy demand driven by cost and expertise differentials.
- Gradual regulatory clarification and formalization of surrogacy frameworks.
Leading Market Participants
- Major players in the surrogacy market include New Hope Fertility Center (USA), Bourn Hall Clinic (UK), IVI RMA Global (Spain), SCR Medical (India), Houston Fertility Institute (USA), Monash IVF Group (Australia), Virtus Health (Australia), Nova IVF Fertility (India), Bangkok IVF Center (Thailand), Reprofit International (Czech Republic).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 32.75 billion
- 2027 Estimated Market Size: USD 40 billion
- Projected Market Size: USD 307.21 billion by 2036
- Growth Forecast: 25.09% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Technology (In-vitro Fertilization (IVF)) | Service Provider (Fertility Clinics) | Type (Gestational Surrogacy) | Age Group (35-37 Years)
- Emerging Opportunity Segment: Technology (In-vitro Fertilization (IVF)) | Service Provider (Fertility Clinics) | Type (Gestational Surrogacy) | Age Group (Below 35 Years)
Market Growth Drivers and Industry Trends
Increasing infertility rates and delayed parenthood trends
Rising infertility concerns and the growing trend toward delayed parenthood are increasing demand for assisted reproductive pathways, including surrogacy. Delayed family formation can coincide with age-related fertility challenges, while medical conditions and unsuccessful fertility treatments may lead intended parents to consider alternative reproductive options. Greater awareness of fertility services and advances in reproductive medicine are also contributing to broader recognition of surrogacy as a potential pathway to parenthood for individuals and couples facing difficulties with pregnancy.
Cross-border surrogacy demand driven by cost and expertise differentials
Differences in treatment costs, medical expertise, service availability, and legal frameworks across countries can encourage intended parents to explore cross-border surrogacy arrangements. Access to specialized reproductive care and established fertility infrastructure may influence decisions to seek services outside the home country, particularly where domestic options are limited or subject to restrictive conditions. The growth of international reproductive travel is therefore contributing to demand for coordinated medical, legal, and support services associated with cross-border surrogacy.
Gradual regulatory clarification and formalization of surrogacy frameworks
The gradual development of clearer legal and regulatory frameworks is supporting greater structure within the surrogacy market by establishing guidelines for intended parents, surrogates, healthcare providers, and intermediaries. Greater regulatory clarity can address important areas such as eligibility, parental rights, medical responsibilities, contractual arrangements, and ethical safeguards. As jurisdictions refine their approaches to assisted reproduction, clearer frameworks can reduce uncertainty and encourage the development of more formalized and transparent surrogacy services.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing infertility rates and delayed parenthood trends | 3.8% | Short term (≤ 2 yrs) | North America; Europe; Spillover: Asia Pacific | Medium | Fast |
| Cross-border surrogacy demand driven by cost and expertise differentials | 3.4% | Medium term (2–5 yrs) | Asia Pacific; Latin America; Spillover: Europe | High | Moderate |
| Gradual regulatory clarification and formalization of surrogacy frameworks | 2.1% | Long term (5+ yrs) | Europe; North America; Spillover: Asia Pacific | High | Slow |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
North America held the largest share in 2026, led by the increasing prevalence of fertility challenges, growing acceptance of assisted reproductive services, and the availability of advanced fertility care infrastructure. Surrogacy has become an important reproductive option for individuals and couples who are unable to carry a pregnancy due to medical or biological circumstances. The region benefits from established fertility clinics, specialized reproductive healthcare professionals, and access to advanced assisted reproductive technologies, creating a well-developed ecosystem for surrogacy services. Growing awareness of available family-building options is also encouraging more individuals to consider surrogacy as part of their reproductive planning. In addition, legal frameworks and established professional support services in several jurisdictions provide greater structure around the surrogacy process, including medical care, counseling, and legal arrangements. Continued advances in reproductive medicine and increasing demand for alternative pathways to parenthood are expected to support market expansion across North America.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is expected to grow at the fastest rate, influenced by increasing infertility concerns, improving reproductive healthcare infrastructure, and growing awareness of assisted reproductive technologies. Rising demand for fertility treatments is encouraging the development of specialized reproductive care facilities and expanding access to fertility-related services across emerging markets. Improvements in medical technology and the availability of skilled reproductive healthcare professionals are also supporting the development of surrogacy-related services. In addition, changing family structures, delayed parenthood, and increasing awareness of alternative reproductive options are contributing to greater interest in assisted reproductive solutions. The expansion of healthcare facilities and improving access to specialized fertility services are expected to create further opportunities for the surrogacy market, although regulatory differences across countries continue to shape the availability and structure of these services.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
United States 🇺🇸
Structured Fertility ServicesThe U.S. surrogacy market is supported by established fertility-service networks and specialized providers coordinating medical, legal, and administrative requirements. Market priorities include reliable patient support, transparent process management, access to reproductive specialists, and structured coordination throughout the surrogacy journey.
Germany 🇩🇪
Regulated Reproductive CareGermany's surrogacy market is strongly shaped by its regulatory environment surrounding assisted reproduction and related reproductive services. Commercial activity therefore places greater emphasis on compliant care pathways, patient counseling, cross-border coordination, and access to permissible fertility services.
Japan 🇯🇵
Specialized Fertility SupportJapan's surrogacy market involves specialized reproductive-care considerations within a tightly regulated environment. Providers and prospective parents place importance on medical coordination, counseling, legal clarity, and structured support for arrangements that may involve domestic limitations or international fertility services.
South Korea 🇰🇷
Cross-Border Fertility CoordinationSouth Korea's surrogacy market is influenced by regulatory and practical constraints that can encourage consideration of international arrangements. Market priorities include fertility consultation, legal guidance, medical coordination, and reliable support for individuals navigating complex cross-border reproductive pathways.
France 🇫🇷
Regulatory-Constrained AccessFrance's surrogacy market is primarily shaped by legal and regulatory restrictions surrounding the practice. Commercially relevant activity therefore centers more on fertility counseling, legal navigation, and cross-border coordination for individuals exploring reproductive options outside the domestic framework.
Italy 🇮🇹
Legal Navigation ServicesItaly's surrogacy market is significantly influenced by legal constraints surrounding reproductive arrangements. Market priorities consequently include specialized counseling, legal guidance, fertility coordination, and support for individuals considering permissible reproductive pathways or arrangements involving services outside the domestic market.
Surrogacy Market Share (%), by Technology, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportTechnology Segment Analysis: In-vitro Fertilization (IVF) (Largest & Fastest-Growing Segment)
The in-vitro fertilization (IVF) technology segment accounted for 60.86% market share in 2026 and is also expected to register the fastest growth, supported by the central role of IVF in enabling gestational surrogacy and addressing complex fertility requirements. IVF allows embryos to be created outside the body and subsequently transferred to a gestational carrier, providing a structured medical pathway for intended parents who require third-party reproductive assistance. Continued improvements in embryo assessment, laboratory procedures, cryopreservation, and reproductive monitoring are strengthening the clinical capabilities associated with IVF-based surrogacy. The technology also provides greater flexibility in coordinating fertility treatment, embryo storage, and transfer procedures, which is important when surrogacy involves multiple stages of medical and legal preparation. Increasing awareness of assisted reproductive options and the growing demand for medically supported family-building pathways are further reinforcing IVF adoption. As fertility care becomes increasingly integrated with specialized reproductive services, IVF is expected to remain a central technology in the surrogacy landscape.
Service Provider Segment Analysis: Fertility Clinics (Largest & Fastest-Growing Segment)
The fertility clinics segment accounted for a 60.77% market share in 2026 and is also expected to experience the fastest growth, reflecting the specialized medical infrastructure required to coordinate fertility treatment and surrogacy procedures. Fertility clinics provide essential services across reproductive assessment, ovarian stimulation, IVF procedures, embryo development, cryopreservation, and embryo transfer, making them a central point of care for intended parents and gestational carriers. Their specialized laboratory facilities and reproductive medicine expertise enable multiple stages of the treatment pathway to be managed in an integrated clinical environment. Fertility clinics can also coordinate closely with reproductive specialists, embryology teams, and other care providers, helping ensure continuity throughout complex treatment cycles. Growing demand for assisted reproductive technologies is encouraging clinics to expand their capabilities and adopt more advanced laboratory and monitoring practices. As prospective parents increasingly seek structured and medically supervised fertility pathways, specialized fertility clinics are expected to remain an important service provider in the surrogacy market.
Type Segment Analysis: Gestational Surrogacy (Largest & Fastest-Growing Segment)
The gestational surrogacy segment represents the largest market share in 2026 and is also expected to grow at the fastest pace, supported by its widespread use as a medically structured approach to third-party reproduction. In gestational surrogacy, the carrier does not provide the egg used to create the embryo, allowing the intended parents or donors to have a biological connection to the resulting child while the carrier provides the pregnancy. This distinction can make gestational arrangements particularly relevant for individuals and couples who require a carrier but seek to use their own genetic material or donor-assisted embryos. The process also integrates closely with IVF, enabling embryo creation, screening where appropriate, cryopreservation, and transfer to be coordinated as part of a specialized fertility-care pathway. Increasing access to reproductive medicine, greater awareness of assisted family-building options, and advances in fertility laboratory practices are supporting the continued use of gestational surrogacy. Its established clinical framework and compatibility with modern reproductive technologies reinforce its importance in the broader surrogacy market.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Technology | Intrauterine Insemination (IUI), In-vitro Fertilization (IVF), Others | In-vitro Fertilization (IVF) | In-vitro Fertilization (IVF) |
| Service Provider | Hospitals, Fertility Clinics, Others | Fertility Clinics | Fertility Clinics |
| Type | Gestational Surrogacy, Traditional Surrogacy | Gestational Surrogacy | Gestational Surrogacy |
| Age Group | Below 35 Years, 35-37 Years, 38 - 39 Years, 40-42 Years, 43-44 Years, Over 44 Years | 35-37 Years | Below 35 Years |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Analyst Perspective:
Cross-border legal complexity and rigorous transparency standards fundamentally govern market positioning within the surrogacy sector. Because legal frameworks and parental recognition rules vary sharply across regions, agency credibility rests on providing structured legal guidance and compliance protocols for international clients. Clinically, differentiation moves past raw success statistics; providers are evaluated on how clearly they distinguish per-transfer success rates from live birth outcomes while communicating medical risks openly. Financial clarity is equally decisive, with leading agencies utilizing structured, transparent cost models that disclose potential contingency expenses upfront. Ultimately, long-term brand equity depends on holistic surrogate care models that incorporate continuous medical oversight, legal safeguards, and psychological support throughout the entire journey.
Major players in the surrogacy market:
- New Hope Fertility Center (USA)
- Bourn Hall Clinic (UK)
- IVI RMA Global (Spain)
- SCR Medical (India)
- Houston Fertility Institute (USA)
- Monash IVF Group (Australia)
- Virtus Health (Australia)
- Nova IVF Fertility (India)
- Bangkok IVF Center (Thailand)
- Reprofit International (Czech Republic)
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| New Hope Fertility Center (USA) | |||||||
| Bourn Hall Clinic (UK) | |||||||
| IVI RMA Global (Spain) | |||||||
| SCR Medical (India) | |||||||
| Houston Fertility Institute (USA) | |||||||
| Monash IVF Group (Australia) | |||||||
| Virtus Health (Australia) | |||||||
| Nova IVF Fertility (India) | |||||||
| Bangkok IVF Center (Thailand) | |||||||
| Reprofit International (Czech Republic) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Overture Life | April 2025 | Overture Life successfully raised USD 20.6 million in funding aimed at scaling its in vitro fertilization automation platforms and advancing operational capabilities in reproductive technology. |
| GED Capital | November 2023 | Spanish investment firm GED Capital and fertility group IVIRMA Global acquired Barcelona-based fertility business Eugin Group in a transaction valued at up to EUR 500 million, including earn-outs, facilitating expansion into the North American market. |
| Kindbody | August 2022 | Kindbody acquired Chicago-based Alternative Reproductive Resources, a gestational surrogacy agency, integrating surrogacy services in-house to secure a seamless continuum of patient care and incorporating the team into its KindEOS division. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Surrogacy Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Intended Parent Type | Heterosexual Couples, Same-Sex Couples, Single Intended Parents |
| Legal Arrangement | Domestic Surrogacy, International Surrogacy |
| Insurance Coverage | Fully Covered, Partially Covered, Self-Pay |
Surrogacy Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Cross-Border Surrogacy Pathways |
|
| Legal Risk & Contract Structures |
|
| Patient Acquisition & Referral Ecosystem |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
What is the overall size of the surrogacy market?
What is the projected value of the surrogacy industry by 2036?
How are infertility and delayed parenthood trends influencing demand for surrogacy services?
How is regulatory clarification shaping the development of the surrogacy market?
Why does IVF dominate the surrogacy market?
Why are fertility clinics important to surrogacy market growth?
What factors make North America the leading surrogacy market?
Why is the surrogacy market growing fastest in Asia Pacific?
Who holds a significant market share in the surrogacy landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook